Neurim Pharmaceuticals is a neuroscience drug discovery and development company creating drugs for brain restoration & reinforcement, focusing on the central nervous system.
Its first approved drug, Circadin® – prolonged release melatonin for insomnia is commercially available in Europe, Asia-Pacific, Latin America, Africa and the Middle East.
Neurim Pharmaceuticals has a promising pipeline of New Chemical Entities effective in Central Nervous System disorders.
The company focuses on the diseases of aging, such as insomnia and neuro-degenerative diseases, with the goal of improving quality of life.
